助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   fentanyl system 的翻译结果: 查询用时:0.007秒
图标索引 在分类学科中查询
所有学科
临床医学
更多类别查询

图标索引 历史查询
 

fentanyl system
相关语句
  芬太尼贴剂
     Observation of the Effect of Applying Fentanyl System in Curing Cancer Pain and Nursing—83 Cases
     应用芬太尼贴剂治疗癌痛的疗效观察及护理83例
短句来源
     The direct conversion ratio from oral morphine to transdermal fentanyl system (TFS) was 100:1 daily.
     40例晚期癌痛患者作为研究对象 ,试验前口服吗啡的患者按 10 0 :1的比例转换为芬太尼贴剂 ;
短句来源
     Conclusion: The treatment effective of transdermal fentanyl system is reliabal in preventing cancer pain of advanced nasopharyngeal carcinoma.
     结论 :芬太尼贴剂治疗鼻咽癌晚期癌痛疗效可靠。
短句来源
  芬太尼贴
     Observation of the Effect of Applying Fentanyl System in Curing Cancer Pain and Nursing—83 Cases
     应用芬太尼贴剂治疗癌痛的疗效观察及护理83例
短句来源
     The direct conversion ratio from oral morphine to transdermal fentanyl system (TFS) was 100:1 daily.
     40例晚期癌痛患者作为研究对象 ,试验前口服吗啡的患者按 10 0 :1的比例转换为芬太尼贴剂 ;
短句来源
     Conclusion: The treatment effective of transdermal fentanyl system is reliabal in preventing cancer pain of advanced nasopharyngeal carcinoma.
     结论 :芬太尼贴剂治疗鼻咽癌晚期癌痛疗效可靠。
短句来源
  “fentanyl system”译为未确定词的双语例句
     Response of Transdermal Fentanyl System to Severe Pain of Advanced Lung Carcinoma
     治疗肺癌晚期癌痛芬太尼透皮贴剂的疗效观察
短句来源
     Objective: To investigate the efficacy , side effects of transdermal fentanyl system in preventing cancer pain of nasopharyngeal carcinoma.
     目的 :观察芬太尼透皮贴剂治疗鼻咽癌癌痛的效果及其不良反应。
短句来源
     Methods: 40 patients with moderate or severe cancer pain of nasopharyngeal carcinoma were treated by transdermal fentanyl system.
     方法 :鼻咽癌中、重度癌痛 4 0例使用芬太尼透皮贴剂。
短句来源
     The objective is to evaluate the effect and toxicity of the low-dose transdermal fentanyl system (or Duragesic) for medium cancer pain, and to investigate the satisfactory rate for Duragesic’s effect.
     为了观察小剂量芬太尼透皮贴剂治疗中度慢性癌痛的疗效、不良反应及满意度。 将 43例中度癌痛患者 ,根据既往使用的镇痛药决定芬太尼初始剂量并分为 2组。
短句来源
查询“fentanyl system”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


Objective To investigate the response rate of transdermal fentanyl system or Duragesic to relieve bone pain by bone metastases. Methods From October 1999 to April 2000 60 patients suffered from middle or serious bone pain caused by bone metastases were randomly divided into 2.5mg and 5.0mg treatment groups. Each group consisted of 30 patients. Therapeutic response quality of life and toxic effect were studied. Results The response rate of 2.5mg and 5.0mg groups were 70% and 74% respectively....

Objective To investigate the response rate of transdermal fentanyl system or Duragesic to relieve bone pain by bone metastases. Methods From October 1999 to April 2000 60 patients suffered from middle or serious bone pain caused by bone metastases were randomly divided into 2.5mg and 5.0mg treatment groups. Each group consisted of 30 patients. Therapeutic response quality of life and toxic effect were studied. Results The response rate of 2.5mg and 5.0mg groups were 70% and 74% respectively. The initial time of effect of these two groups were 3.2 and 2.8 hours and it could be sustained for 53.4 and 60.6 hours respectively even without significant difference P>0.05. But the difference of bone pain score and Karnofsy value before and after treatment was significant P<0.05. The main toxic effects were nausea vomiting dizziness constipation somnolence etc. Conclusion Transdermal fentanyl system is one kind of effective analgesics for bone pain especially for middle and serious bone pain. Although the therapeutic effect of 2.5mg and 5.0mg dosage has no significant difference but the toxic effect of duragesic must be emphasized.

目的:观察芬太尼透皮贴剂治疗恶性肿瘤合并骨转移所致骨痛的效果。方法:从1999年10月起,将60例骨转移瘤伴有中度以上疼痛的患者随机分成2.5mg/贴和5.0mg/贴两个治疗组,每组30例,观察其止痛疗效、生活质量的变化及毒副作用。结果:两治疗组止痛显效率分别为70%和74%,平均起效时间分别为3.2和2.8小时,平均止痛持续时间分别为53.4和60.6小时,差异无显著性;骨痛和生活质量Karnofsy评分治疗前后差异有显著性;但两组之间比较,无统计学意义。芬太尼透皮贴剂常见的毒副作用是头晕、恶心呕吐、便秘、嗜睡等症状,并以5.0mg治疗组副作用大。结论:芬太尼贴剂作为长效麻醉止痛药,具有使用方便、疗效确定和毒副作用小的特点。虽然,2.5mg/贴和5.0mg/贴两个治疗组比较,差异无显著性;但从表面看,2.5mg/贴和5.0mg/贴两种剂型药物总有效率、其起效时间和持续时间略有差异,但毒副作用以5.0mg芬太尼为重。

Objective To evaluate the pain control, general condition and well-being of the patients with advanced cancer treated with transdermal fentanyl as well as the effects of transdermal fentanyl on heart rate variability (HRV) and endocrine function. Methods This open prospective study included 40 patients with advanced cancer. The direct conversion ratio from oral morphine to transdermal fentanyl system (TFS) was 100:1 daily. In patients who had never received any opioid before the initial dose of TFS...

Objective To evaluate the pain control, general condition and well-being of the patients with advanced cancer treated with transdermal fentanyl as well as the effects of transdermal fentanyl on heart rate variability (HRV) and endocrine function. Methods This open prospective study included 40 patients with advanced cancer. The direct conversion ratio from oral morphine to transdermal fentanyl system (TFS) was 100:1 daily. In patients who had never received any opioid before the initial dose of TFS was 25μg/h. The transdermal system was changed every 72h and the dosage was adjusted to the need of the patients according to the VAS scores and the requirement of morphine. 8 hospitalized patients were monitored by 24h Holter for changes in HRV. Blood samples were taken before transdermal fentanyl patch when pain was severe and 24h after TFS for determination of ACTH,β-endorphin, growth hormone(GH) and insulin levels.Results Pain relief during treatment with transdermal fentanyl was significant accoring to VAS scores. Well-being scores showed that patients' quality of life including appetite, sleep, mental state and daily activities was significantly improved after two weeks treatment. The ratio of LF vs HF, which is one of HRV frequency indices, was obviously reduced at 24h after transdermal fentanyl patch as compared with that before TFS (P<0.05). TFS significantly reduced plasma ACTH, β-endorphin and insulin levels, but the change in GH was not significant. No respiratory depression was observed. The incidences of constipation, nausea and vomiting and skin pruritus did not markedly changed following long-term TFS.Conclusions Transdermal fentanyl provides an effective , safe treatment modality in patients with cancer pain with low side effects.

目的 评价芬太尼贴剂的镇痛效果 ,和对心率变异性 (HRV)及机体应激状态的影响。方法 本研究为前瞻、开放试验。 40例晚期癌痛患者作为研究对象 ,试验前口服吗啡的患者按 10 0 :1的比例转换为芬太尼贴剂 ;未用过阿片类药物者 ,初始芬太尼剂量为 2 5 μg/h贴剂。透皮系统每 72h更换一次 ,剂量根据患者疼痛自我评分 (VAS)和对注射吗啡的需要量调整。结果 芬太尼贴剂治疗期间患者疼痛明显缓解 ,VAS评分与治疗前相比明显降低 (P <0 0 1)。治疗 2周时 ,问卷调查显示患者的睡眠、精神状态以及日常生活较治疗前明显改善。贴剂治疗 2 4h后HRV的低频功率 (LF)与高频功率 (HF)之比明显低于治疗前 ,而应激激素促肾上腺皮质激素 (ACTH)、β 内啡肽和胰岛素也明显降低 (P <0 0 1) ,但生长激素波动不明显。无一例发生呼吸抑制 ,便秘、恶心呕吐及皮肤瘙痒发生率 ,用药前后均无显著性变化。结论 芬太尼贴剂用于治疗晚期癌痛有效、安全、副作用小 ,其良好的镇痛效果对机体的应激反应和植物神经功能平衡均产生有益影响

Objective To investigate the efficacy,side effects of transdermal fentanyl system in patients with severe pain of lung carcinoma.Methods 40 patients with moderate or severe pain of lung carcinoma were treated by transdermal fentanly system.With multicenter random opening trial,the initial dosage was 25 μg/h or based on the Conversion Table of Morphine Dosage over Durogesic,it was changed every three days,and adjusted the dosage according to pain intensity,until painlessness or nearly painlessness.Results...

Objective To investigate the efficacy,side effects of transdermal fentanyl system in patients with severe pain of lung carcinoma.Methods 40 patients with moderate or severe pain of lung carcinoma were treated by transdermal fentanly system.With multicenter random opening trial,the initial dosage was 25 μg/h or based on the Conversion Table of Morphine Dosage over Durogesic,it was changed every three days,and adjusted the dosage according to pain intensity,until painlessness or nearly painlessness.Results The moderate or more relief rate was 100%,and in which complete relief rate was 62.5%,obvious relief was 37.5%.The main side effects are constipation,dizziness,nausea,lethargy and pruritus.But severe side effects didn't appear.Conclusions The treatment effect of transdermal fentanly system was reliable for cancer pain of advanced lung carcinoma.

目的 观察芬太尼透皮贴剂治疗肺癌癌痛的效果及其不良反应。方法  40例肺癌中、重度癌痛的患者 ,使用芬太尼透皮贴剂。采用多中心随机开放实验 ,初始剂量 2 5 μg/h或参照吗啡与贴剂折算表使用 ,每 3天更换 1次 ,并根据疼痛情况调整剂量 ,直至患者达到满意的镇痛。结果 疼痛中度以上缓解达到 10 0 % ,其中完全缓解 62 5 % ,明显缓解 37 5 %。芬太尼贴剂的主要不良反应为便秘、头晕、恶心、嗜睡、皮肤搔痒 ,未出现呼吸抑制等严重不良反应。结论 芬太尼透皮贴剂治疗肺癌晚期癌痛疗效可靠

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关fentanyl system的内容
在知识搜索中查有关fentanyl system的内容
在数字搜索中查有关fentanyl system的内容
在概念知识元中查有关fentanyl system的内容
在学术趋势中查有关fentanyl system的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社